Trypanosoma cruzi infection is enhanced by vector saliva through immunosuppressant mechanisms mediated by lysophosphatidylcholine.

Mesquita RD, Carneiro AB, Bafica A, Gazos-Lopes F, Takiya CM, Souto-Padron T, Vieira DP, Ferreira-Pereira A, Almeida IC, Figueiredo RT, Porto BN, Bozza MT, Gra?a-Souza AV, Lopes AH, Atella GC, Silva-Neto MA. Trypanosoma cruzi infection is enhanced by vector saliva through immunosuppressant mechanisms mediated by lysophosphatidylcholine. Infect Immun. 2008 Dec; 76(12):5543-52.

View in: PubMed

subject areas

Animals
Chagas Disease
Chemotaxis, Leukocyte
Chromatography, Thin Layer
Cytokines
Humans
Immunosuppressive Agents
Insect Vectors
Lysophosphatidylcholines
Macrophages
Male
Mice
Neutrophil Infiltration
Nitric Oxide
Parasitemia
Rhodnius
Saliva
Trypanosoma cruzi

authors with profiles

Igor C. Almeida

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support